Zobrazeno 1 - 7
of 7
pro vyhledávání: '"59"'
Autor:
Xiaobin Zheng, Zhinan Xie, Cuiling Zhou, Haiqing Ma, Huanhuan Sun, Junlan Qiu, Xiaofeng Pei, Gang Che, Hongyu Zhang, Yunyan Cong
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 145:2663-2674
It is known that there are insufficient prognostic factors for non-small cell lung cancer (NSCLC). It was reported that PD-L1 was a prognostic factor for NSCLC,and c-Myc regulated the expression of PD-L1. Herein, we investigated c-Myc and PD-L1 expre
Publikováno v:
Journal of cancer research and clinical oncology. 145(7)
To study integrin α6 expression in lung adenocarcinoma tissue through comparison with matching adjacent non-cancerous tissues as well as elucidating the correlation between integrin α6 expression with the clinical parameters of lung adenocarcinoma.
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 139:1523-1528
Fibroblast activation protein-α (FAP-α), which is a serine protease specially expressed on the surface of the cancer stromal cells, plays an important role in the progression and prognosis in diverse malignancies. However, the role of FAP-α in non
Autor:
Alberto Cianetti, Gianluca Costa, Paola Vannini, Gianluca Mazzoni, Adriano Tocchi, Gianluca Liotta, Luca Lepre
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 124:450-455
Purpose: The aim of the present study was to investigate carcinoembryonic antigen (CEA), CA19.9, and CA72.4 in the serum and gastric juice of patients with gastric cancer. Methods: Serum and gastric juice tumor markers CEA, CA19.9, and CA72.4 were me
Publikováno v:
Journal of cancer research and clinical oncology. 139(4)
Adiponectin, an adipocyte-secreted endogenous insulin sensitizer, appears to play an important role in progression of several malignancies. Expression of adiponectin receptors—AdipoR1 and AdipoR2—has been documented in gastric cancer (GC) cell li
Autor:
Michael Murawsky, Marcus Hudec, M. Baur, Christian Dittrich, May Klink-Alakl, Michèle Tubiana-Hulin, Allan T. van Oosterom, Véronique Diéras, R. Charles Coombes, Thomas Hatschek
Publikováno v:
Journal of cancer research and clinical oncology. 134(2)
The efficacy and tolerability of docetaxel 100 mg/m(2) every 3 weeks as second-line chemotherapy in patients with metastatic breast cancer was investigated. In addition, the efficacy of a 3-day prophylaxis against cumulative dose-related fluid retent
Autor:
Nejat K. Egilmez, J. M. Lenox, Timothy M. Anderson, Chukwumere Nwogu, Stephen D. Hess, Richard B. Bankert
Publikováno v:
Journal of cancer research and clinical oncology. 129(10)
Leukemic cell growth in SCID mice has been reported as a predictor of disease relapse. However, there is a paucity of literature regarding xenograft growth and clinical outcomes in non-small cell lung cancer (NSCLC). Seventy-nine specimens from patie